97 related articles for article (PubMed ID: 9673797)
1. Cutaneous Merkel cells of the rat contain both dynorphin A and vesicular monoamine transporter type 1 (VMAT1) immunoreactivity.
Weihe E; Hartschuh W; Schäfer MK; Romeo H; Eiden LE
Can J Physiol Pharmacol; 1998 Mar; 76(3):334-9. PubMed ID: 9673797
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours.
Jakobsen AM; Andersson P; Saglik G; Andersson E; Kölby L; Erickson JD; Forssell-Aronsson E; Wängberg B; Ahlman H; Nilsson O
J Pathol; 2001 Nov; 195(4):463-72. PubMed ID: 11745679
[TBL] [Abstract][Full Text] [Related]
3. Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat.
Weihe E; Schäfer MK; Erickson JD; Eiden LE
J Mol Neurosci; 1994; 5(3):149-64. PubMed ID: 7654518
[TBL] [Abstract][Full Text] [Related]
4. Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut.
Schütz B; Schäfer MK; Eiden LE; Weihe E
Brain Res Dev Brain Res; 1998 Mar; 106(1-2):181-204. PubMed ID: 9555003
[TBL] [Abstract][Full Text] [Related]
5. Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions.
Pickel VM; Chan J; Nirenberg MJ
Synapse; 2002 Aug; 45(2):113-24. PubMed ID: 12112404
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-alpha directly augments histidine decarboxylase and vesicular monoamine transporter 2 production in rat enterochromaffin-like cells.
Kazumori H; Ishihara S; Rumi MA; Ortega-Cava CF; Kadowaki Y; Kinoshita Y
Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G508-14. PubMed ID: 14563668
[TBL] [Abstract][Full Text] [Related]
7. Expression of vesicular monoamine transporters, synaptosomal-associated protein 25 and syntaxin1: a signature of human small cell lung carcinoma.
Graff L; Castrop F; Bauer M; Höfler H; Gratzl M
Cancer Res; 2001 Mar; 61(5):2138-44. PubMed ID: 11280778
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase A affects trafficking of the vesicular monoamine transporters in PC12 cells.
Yao J; Erickson JD; Hersh LB
Traffic; 2004 Dec; 5(12):1006-16. PubMed ID: 15522101
[TBL] [Abstract][Full Text] [Related]
9. Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors.
Anlauf M; Eissele R; Schäfer MK; Eiden LE; Arnold R; Pauser U; Klöppel G; Weihe E
J Histochem Cytochem; 2003 Aug; 51(8):1027-40. PubMed ID: 12871984
[TBL] [Abstract][Full Text] [Related]
10. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.
Erickson JD; Schafer MK; Bonner TI; Eiden LE; Weihe E
Proc Natl Acad Sci U S A; 1996 May; 93(10):5166-71. PubMed ID: 8643547
[TBL] [Abstract][Full Text] [Related]
11. Modulation of gastrin processing by vesicular monoamine transporter type 1 (VMAT1) in rat gastrin cells.
Hussain I; Bate GW; Henry J; Djali P; Dimaline R; Dockray GJ; Varro A
J Physiol; 1999 Jun; 517 ( Pt 2)(Pt 2):495-505. PubMed ID: 10332097
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of two vesicular monoamine transporters.
Peter D; Liu Y; Sternini C; de Giorgio R; Brecha N; Edwards RH
J Neurosci; 1995 Sep; 15(9):6179-88. PubMed ID: 7666200
[TBL] [Abstract][Full Text] [Related]
13. The vesicular monoamine transporter 2 (VMAT2) is expressed by normal and tumor cutaneous mast cells and Langerhans cells of the skin but is absent from Langerhans cell histiocytosis.
Anlauf M; Schafer MK; Depboylu C; Hartschuh W; Eiden LE; Kloppel G; Weihe E
J Histochem Cytochem; 2004 Jun; 52(6):779-88. PubMed ID: 15150286
[TBL] [Abstract][Full Text] [Related]
14. Evidence for histamine as a transmitter in rat carotid body sensor cells.
Koerner P; Hesslinger C; Schaefermeyer A; Prinz C; Gratzl M
J Neurochem; 2004 Oct; 91(2):493-500. PubMed ID: 15447682
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.
Staal RG; Sonsalla PK
J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000
[TBL] [Abstract][Full Text] [Related]
16. Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes.
Anlauf M; Schäfer MK; Eiden L; Weihe E
J Comp Neurol; 2003 Apr; 459(1):90-111. PubMed ID: 12629668
[TBL] [Abstract][Full Text] [Related]
17. Transient developmental expression of monoamine transporters in the rodent forebrain.
Lebrand C; Cases O; Wehrlé R; Blakely RD; Edwards RH; Gaspar P
J Comp Neurol; 1998 Nov; 401(4):506-24. PubMed ID: 9826275
[TBL] [Abstract][Full Text] [Related]
18. The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP).
Numis AL; Unger EL; Sheridan DL; Chisnell AC; Andrews AM
Mol Pharmacol; 2004 Sep; 66(3):718-27. PubMed ID: 15322265
[TBL] [Abstract][Full Text] [Related]
19. Reserpine- and tetrabenazine-sensitive transport of (3)H-histamine by the neuronal isoform of the vesicular monoamine transporter.
Erickson JD; Eiden LE; Schafer MK; Weihe E
J Mol Neurosci; 1995; 6(4):277-87. PubMed ID: 8860238
[TBL] [Abstract][Full Text] [Related]
20. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
Suzuki M; Desmond TJ; Albin RL; Frey KA
Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
